AR001858A1 - A therapeutically effective or diagnostic agent composition - Google Patents

A therapeutically effective or diagnostic agent composition

Info

Publication number
AR001858A1
AR001858A1 AR33640796A AR33640796A AR001858A1 AR 001858 A1 AR001858 A1 AR 001858A1 AR 33640796 A AR33640796 A AR 33640796A AR 33640796 A AR33640796 A AR 33640796A AR 001858 A1 AR001858 A1 AR 001858A1
Authority
AR
Argentina
Prior art keywords
therapeutically effective
agent composition
diagnostic agent
macromolecular structures
well
Prior art date
Application number
AR33640796A
Other languages
Spanish (es)
Original Assignee
Polymasc Pharmaceuticals Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polymasc Pharmaceuticals Plc filed Critical Polymasc Pharmaceuticals Plc
Publication of AR001858A1 publication Critical patent/AR001858A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La administración de agentes de diagnóstico y terapéuticos a la piel o a tumores sólidos es perfeccionada mediante la optimización de las estructurasmacromoleculares que contienen lípidos (por ejemplo liposomas) que encapsulan los agentes y elt ipo y cantidad de porciones hidrofílicas unidas al exteriorde las estructuras macromoleculares, así como también las proporciones relativas de los varios lípidos, u otras entidades hidrófobas que forman lasestructuras macromoleculares.The administration of diagnostic and therapeutic agents to the skin or to solid tumors is enhanced by optimizing the lipid-containing macromolecular structures (eg, liposomes) that encapsulate the agents and the type and amount of hydrophilic portions attached to the exterior of the macromolecular structures, as well as well as the relative proportions of the various lipids, or other hydrophobic entities that form the macromolecular structures.

AR33640796A 1995-05-03 1996-05-03 A therapeutically effective or diagnostic agent composition AR001858A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9509016.3A GB9509016D0 (en) 1995-05-03 1995-05-03 Tissue entrapment

Publications (1)

Publication Number Publication Date
AR001858A1 true AR001858A1 (en) 1997-12-10

Family

ID=10773939

Family Applications (1)

Application Number Title Priority Date Filing Date
AR33640796A AR001858A1 (en) 1995-05-03 1996-05-03 A therapeutically effective or diagnostic agent composition

Country Status (7)

Country Link
EP (1) EP0825850A1 (en)
JP (1) JPH11504915A (en)
AR (1) AR001858A1 (en)
AU (1) AU5509796A (en)
CA (1) CA2218932A1 (en)
GB (1) GB9509016D0 (en)
WO (1) WO1996034598A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645463B1 (en) 1994-05-16 2003-11-11 The Board Of Regents Of The University Of Michigan Blood-pool selective carrier for lipophilic imaging agents
US5820873A (en) * 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof
US5885613A (en) * 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US6673364B1 (en) 1995-06-07 2004-01-06 The University Of British Columbia Liposome having an exchangeable component
JP2001524957A (en) * 1997-04-11 2001-12-04 ザ ボード オブ リージェンツ オブ ザ ユニヴァーシティ オブ ミシガン Blood pool carrier for lipophilic diagnostic imaging agents
US6734171B1 (en) 1997-10-10 2004-05-11 Inex Pharmaceuticals Corp. Methods for encapsulating nucleic acids in lipid bilayers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720857B2 (en) * 1988-08-11 1995-03-08 テルモ株式会社 Liposome and its manufacturing method
GB8824593D0 (en) * 1988-10-20 1988-11-23 Royal Free Hosp School Med Liposomes
US5356633A (en) * 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
US5527528A (en) * 1989-10-20 1996-06-18 Sequus Pharmaceuticals, Inc. Solid-tumor treatment method
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
CA2073680C (en) * 1990-04-18 2001-07-03 Katsumi Iga Liposome composition
JP3220180B2 (en) * 1991-05-23 2001-10-22 三菱化学株式会社 Drug-containing protein-bound liposomes
US6326353B1 (en) * 1993-03-23 2001-12-04 Sequus Pharmaceuticals, Inc. Enhanced circulation effector composition and method

Also Published As

Publication number Publication date
AU5509796A (en) 1996-11-21
EP0825850A1 (en) 1998-03-04
JPH11504915A (en) 1999-05-11
GB9509016D0 (en) 1995-06-21
WO1996034598A1 (en) 1996-11-07
CA2218932A1 (en) 1996-11-07

Similar Documents

Publication Publication Date Title
PT733357E (en) PHARMACEUTICAL FORMULATIONS IN THE FORM OF TIXOTROPIC GEL
ATE337019T1 (en) CHARGED LIPIDS AND THEIR USE
AR025071A1 (en) ADDITIVE TO IMPROVE WATER RESISTANCE OF COSMETIC OR DERMATOLOGICAL FORMULATIONS
ES2192586T3 (en) FORMULATIONS AND PROCEDURES TO REDUCE SKIN IRRITATION.
LV10180A (en) Pharmaceutical composition
ES2134776T3 (en) MICROCRYSTALS COATED WITH PHOSPHOLIPIDS: INJECTABLE FORMULATIONS OF INSOLUBLE MEDICINES IN WATER.
ES2171971T3 (en) CLEANING AND TREATMENT PRODUCT WITH ALMIDON.
ATE51522T1 (en) FORMULATION OF NON-IRRITTING OPHTHALMIC AQUEOUS COMPOSITIONS FOR OCULAR THERAPEUTIC AGENT.
DE69620136T2 (en) ANTIBACTERIAL PREPARATIONS FOR THE EARS WITHOUT IRRITATING, SENSITIZING AND OTOTOXIC EFFECTS
ES2170259T3 (en) EMPLOYMENT OF LIPIDS AS AUXILIARY AGENTS IN OBTAINING SOLID PHARMACEUTICAL FORMS ACCORDING TO THE FUSION EXTRUSION PROCEDURE.
NO831084L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUARTERS DIBENZOTIEPIN-N-ALKYL-NORSCOPINETERS
CO5160321A1 (en) NEW COMPOSITIONS OF TIPRANAVIR AND RITONAVIR
BR9809117A (en) Composition of delayed release gel, process of producing the same, pharmaceutical formulation, and processes of treatment of an indication, a disease, and inflammation with a composition of prolonged release
RU95103892A (en) COMPOSITION FOR TOPIC APPLICATION FOR HAIR GROWTH STIMULATION AND/OR THEIR FALLING OUT RETARDATION, METHOD OF COSMETIC HAIR TREATMENT, USE OF α-PYRONE DERIVATIVE FOR COMPOSITION PREPARING
AR001858A1 (en) A therapeutically effective or diagnostic agent composition
CO4700420A1 (en) TRANSDERMIC FORMULATION
ES2093102T3 (en) METHOD THAT ALLOWS TO REDUCE THE IRRITATING PROPERTIES OF A COSMETIC COMPOSITION.
AR002247A1 (en) ELEUTEROBINA AND ANALOGS OF THE SAME AND COMPOSITIONS THAT INCLUDE THEM.
FR2686513B1 (en) AQUEOUS PHARMACEUTICAL COMPOSITIONS OF SODIUM CROMOGLYCATE.
HUP9902415A2 (en) Solid instant-release forms of administration and process for producing the same
BR0009194A (en) Composition of resorcinol
CA2264094A1 (en) Structured water for enhanced moisturization
ES2161913T3 (en) TRINUCLEAR CATIONIC COMPLEXES OF PLATINO THAT HAVE AN ANTITUMORAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
DE69532819D1 (en) CARBOHYDRATE DERIVATIVES AND THE CONTAINING COMPOSITIONS
FR2632525B1 (en) THERAPEUTIC APPLICATION OF HUMAN MYELOPEROXYDASE

Legal Events

Date Code Title Description
FB Suspension of granting procedure